News headlines today are touting a “new study” that shows boys with “Conduct Disorder” have differences in “size and structure of their brain” that MAY be linked to behavior. Before we point out just how lame this new study is on a scientific level – let’s start with the fact that the study was funded by Wellcome Trust. If the name Wellcome sounds familiar it’s because it was named after, and established in order to administer the fortune of American born pharmaceutical giant, Sir Henry Wellcome (Glaxo-Wellcome later became GlaxoSmithKline). Secondly, the study authors admitted, they couldn’t conclude a thing….
WASHINGTON — Drug manufacturer Forest Pharmaceuticals Inc. was sentenced today by U.S. District Judge Nancy Gertner to pay a criminal fine of $150 million and forfeit assets of $14 million following the company’s guilty plea in November 2010 to one felony count of obstructing justice, one misdemeanor count of distributing an unapproved new drug in interstate commerce and one misdemeanor count of distributing a misbranded drug in interstate commerce, the Justice Department announced.
Dr. Maria Carmen Palazzo was a clinical investigator for SmithKline Beecham doing business as GlaxoSmithKline. Prosecutors say that during those studies she included psychiatric diagnoses inconsistent with patients’ psychiatric histories; prepared multiple psychiatric evaluations on study patients which contained different diagnoses and reported symptoms she knew the study subject did not demonstrate.
Ken Kramer, a researcher with the Citizens Commission on Human Rights of Florida, says the numbers underestimate the extent of the problem, because medical examiners do not track deaths attributed to antipsychotic drugs or to antidepressants, both of which carry black-box or black-label warnings. The warnings on antidepressants, required by the Food and Drug Administration, state that the drugs increase the risk of suicidal thinking and behavior in children, adolescents and young adults up to age 24. (Antidepressants include Paxil, Prozac, Zoloft, Effexor, Lexapro and Celexa.)